| 2.22 Real-Time Quote |  +0.02 / +0.91%Today’s Change | 1.51 Today|||52-Week Range 3.96 | +15.63% Year-to-Date |
| Previous close | 2.20 |
| Today’s open | 2.24 |
| Day’s range | 2.20 - 2.28 |
| Volume | 258,492 |
| Average volume (3 months) | 484,650 |
| Market cap | $116.0M |
| Dividend yield | -- |
| Earnings growth (last year) | -66.67% |
| Earnings growth (this year) | +16.43% |
| Earnings growth (next 5 years) | -- |
| Revenue growth (last year) | -- |
| P/E ratio | NM |
| Price/Sales | -- |
| Price/Book | 4.91 |
| Today’s change | Today’s % change | |
|---|---|---|
| ONTYOncothyreon Inc | +0.03 | +1.41% |
| BSTCBiospecifics Technol... | -0.07 | -0.43% |
| CDXSCodexis Inc | -0.08 | -3.07% |
| ENZEnzo Biochem Inc | 0.00 | 0.00% |
| Next reporting date | August 14, 2013 |
| EPS forecast (this quarter) | -$0.07 |
| Annual revenue (last year) | $0.00 |
| Annual profit (last year) | -$14.5M |
| Net profit margin | -- |
Sector Health Technology |
Industry Biotechnology |
Chairman & Chief Scientific Officer John S. Yu, MD |
President, Chief Executive Officer & Director Andrew Gengos, MBA |
Corporate headquarters Woodland Hills, California |
.
